You searched for "AMN"
Fight for Sight to maximise impact by funding solutions-focused research in priority eye conditions
Fight for Sight aims to stop sight loss by funding pioneering research. Rod McNeil takes a look at the Primer Fellowship Awards programme, which provides funding for up to £60,000 for individuals to undertake vision-related research for one year. Among...Management of diabetic macular oedema in vitrectomised eyes
Diabetic macular oedema (DMO) is one of the leading causes of blindness; its prevalence is on the rise with progressive increase in numbers of people suffering from diabetes. The management of DMO has evolved significantly over the past few years....Saving sight and changing lives: working with Syrian refugees in Jordan
Two ophthalmologists from the Emory Eye Center share their three-year experience of treating refugees in the camps in Jordan. Jordan currently hosts an estimated 1.4 million Syrian people who have fled the war in their home country. Cataract & Cornea...Macular Society chief executive, Cathy Yelf, announces retirement
After nearly a decade of dedicated service as chief executive of leading sight loss charity the Macular Society, Cathy Yelf has announced her decision to retire in 2024.At least 70 percent of cataract patients could benefit from toric IOL
More than two-thirds of cataract patients could benefit from toric intraocular lenses (IOL), according to findings presented at 100% Optical. Consultant ophthalmologist Nigel Kirkpatrick set out how astigmatism is a significant issue for cataract surgery patients during a main stage...Optegra announces programme of engaging CPD events for healthcare community
Optegra continues to strengthen its commitment to clinical excellence and community partnership by announcing a series of Continuing Professional Development (CPD) events throughout 2026, open to any health care professionals in optometry. Taking place across a range of dates and...Redefining healthcare through the eyes
The future of healthcare is being shaped by innovation in eyecare and in particular a field known as oculomics. This discipline leverages ocular biomarkers to provide insights into various health conditions, including cardiovascular diseases and psychological or neurological disorders [1]....SILMO 2019: Anything goes, but sustainability grows
Trying to spot the trends at this year’s SILMO in Paris, one of the largest optical fairs in the world, was a tough ask. Thin metals, especially in rose gold, abounded, but that’s now; tomorrow remained elusive.AI breakthrough brings geographic atrophy treatment a step closer
A team led by Dr Konstantinos Balaskas at Moorfields Eye Hospital Reading Centre has developed a fully automated, deep-learning model (algorithm) that can detect and quantify geographic atrophy using standard optical coherence tomography (OCT) scans.Eye Capacity: clinical need should drive ophthalmic service provision
Almost two million people in the UK suffer sight loss, a number forecast to double over coming decades. Major causes of blindness are age-related macular degeneration (AMD), glaucoma, diabetic retinopathy, cataract and uncorrected refractive error. Prevalence of these sight-threatening conditions...
How many injections in nAMD: ranibizumab vs. aflibercept
Intravitreal anti-VEGF injections make up a large proportion of the workload in ophthalmology clinics. Since the introduction of aflibercept with eight weekly injections there has been an option to use a treatment which may require less treatment, with potential cost...
